|
Volumn 8, Issue 4, 2020, Pages e24-
|
COVID-19, ECMO, and lymphopenia: a word of caution
|
Author keywords
[No Author keywords available]
|
Indexed keywords
INTERLEUKIN 6;
ADULT RESPIRATORY DISTRESS SYNDROME;
BIOLOGICAL MODEL;
CORONAVIRUS DISEASE 2019;
CORONAVIRUS INFECTION;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
EXTRACORPOREAL OXYGENATION;
HUMAN;
IMMUNE STATUS;
IMMUNOSUPPRESSIVE TREATMENT;
LETTER;
LONG TERM CARE;
LYMPHOCYTE COUNT;
LYMPHOCYTE FUNCTION;
LYMPHOCYTOPENIA;
NONHUMAN;
PATIENT MONITORING;
PRIORITY JOURNAL;
PROGNOSIS;
RESPIRATORY FAILURE;
SURVIVAL FACTOR;
BETACORONAVIRUS;
CHINA;
CRITICAL ILLNESS;
PANDEMIC;
RETROSPECTIVE STUDY;
SARS CORONAVIRUS;
VIRUS PNEUMONIA;
BETACORONAVIRUS;
CHINA;
CORONAVIRUS INFECTIONS;
CRITICAL ILLNESS;
EXTRACORPOREAL MEMBRANE OXYGENATION;
HUMANS;
LYMPHOPENIA;
PANDEMICS;
PNEUMONIA, VIRAL;
RETROSPECTIVE STUDIES;
SARS VIRUS;
|
EID: 85082312050
PISSN: 22132600
EISSN: 22132619
Source Type: Journal
DOI: 10.1016/S2213-2600(20)30119-3 Document Type: Letter |
Times cited : (211)
|
References (5)
|